95 related articles for article (PubMed ID: 15584995)
1. Hemostatic effect of activated recombinant factor VIIa in Bernard-Soulier syndrome: studies in an in vitro model.
Tonda R; Galán AM; Pino M; Lozano M; Ordinas A; Escolar G
Transfusion; 2004 Dec; 44(12):1790-1. PubMed ID: 15584995
[No Abstract] [Full Text] [Related]
2. Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa.
Peters M; Heijboer H
Thromb Haemost; 1998 Aug; 80(2):352. PubMed ID: 9716174
[No Abstract] [Full Text] [Related]
3. Redistribution and hemostatic action of recombinant activated factor VII associated with platelets.
Lopez-Vilchez I; Hedner U; Altisent C; Diaz-Ricart M; Escolar G; Galan AM
Am J Pathol; 2011 Jun; 178(6):2938-48. PubMed ID: 21641410
[TBL] [Abstract][Full Text] [Related]
4. Clinical benefit of recombinant factor VIIa in management of bleeds and surgery in two brothers suffering from the Bernard-Soulier syndrome.
Tefre KL; Ingerslev J; Sørensen B
Haemophilia; 2009 Jan; 15(1):281-4. PubMed ID: 19149853
[TBL] [Abstract][Full Text] [Related]
5. Use of recombinant factor VIIa in inherited platelet disorders.
Kaleelrahman M; Minford A; Parapia LA
Br J Haematol; 2004 Apr; 125(1):95-6. PubMed ID: 15015980
[No Abstract] [Full Text] [Related]
6. Congenital and acquired platelet disorders: current dilemmas and treatment strategies.
White GC
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S37-41. PubMed ID: 16427384
[TBL] [Abstract][Full Text] [Related]
7. DDAVP shortens bleeding time in Bernard-Soulier syndrome.
Kemahli S; Canatan D; Uysal Z; Akar N; Cin S; Arcasoy A
Thromb Haemost; 1994 May; 71(5):675. PubMed ID: 8091397
[No Abstract] [Full Text] [Related]
8. Use of recombinant factor VIIa in the management and prophylaxis of bleeding episodes in two patients with Bernard-Soulier syndrome.
Hacihanefioglu A; Tarkun P; Gonullu E
Thromb Res; 2007; 120(3):455-7. PubMed ID: 17141823
[No Abstract] [Full Text] [Related]
9. Aggregation to botrocetin in some patients with Bernard-Soulier syndrome.
Howard M; Firkin BG
Am J Hematol; 1991 May; 37(1):61-2. PubMed ID: 2024644
[No Abstract] [Full Text] [Related]
10. Theragnostic performance of ex vivo testing of haemostatic intervention and clinical effect of recombinant factor VIIa and fibrinogen concentrate.
Tang M; Wierup P; Christiansen K; Greisen J; Sørensen B
Thromb Res; 2012 May; 129(5):e263-5. PubMed ID: 22475314
[No Abstract] [Full Text] [Related]
11. Complementary effect of fibrinogen and rFVIIa on clotting ex vivo in Bernard-Soulier syndrome and combined use during three deliveries.
Palsson R; Vidarsson B; Gudmundsdottir BR; Larsen OH; Ingerslev J; Sorensen B; Onundarson PT
Platelets; 2014; 25(5):357-62. PubMed ID: 23909788
[TBL] [Abstract][Full Text] [Related]
12. Efficient tyrosine phosphorylation of proteins after activation of platelets with thrombin depends on intact glycoprotein Ib.
Diaz-Ricart M; Fuste B; Estebanell E; Tonda R; Lozano M; Escolar G; Jamieson G; Ordinas A
Platelets; 2005 Dec; 16(8):453-61. PubMed ID: 16287612
[TBL] [Abstract][Full Text] [Related]
13. DDAVP shortens the bleeding time in Bernard-Soulier syndrome.
Cuthbert RJ; Watson HH; Handa SI; Abbott I; Ludlam CA
Thromb Res; 1988 Mar; 49(6):649-50. PubMed ID: 3388316
[No Abstract] [Full Text] [Related]
14. Bernard Soulier syndrome.
Pati HP; Saraya AK; Choudhry VP
Indian Pediatr; 1991 Feb; 28(2):180-2. PubMed ID: 2055635
[No Abstract] [Full Text] [Related]
15. Artificial contact pathway activation masks the haemostatic potential of rFVIIa and NN1731 in thrombocytopenic whole blood.
Larsen OH; Ezban M; Persson E; Ingerslev J; Sørensen B
Br J Haematol; 2010 Jul; 150(1):124-7. PubMed ID: 20331467
[No Abstract] [Full Text] [Related]
16. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
[TBL] [Abstract][Full Text] [Related]
17. [Recombinant factor VIIa in patients with platelet function disorders or thrombocytopenia].
Zotz RB; Scharf RE
Hamostaseologie; 2007 Sep; 27(4):251-62. PubMed ID: 17938763
[TBL] [Abstract][Full Text] [Related]
18. Successful pregnancy outcome in Bernard-Soulier syndrome.
Kriplani A; Singh BM; Sowbernika R; Choudhry VP
J Obstet Gynaecol Res; 2005 Feb; 31(1):52-6. PubMed ID: 15669993
[TBL] [Abstract][Full Text] [Related]
19. [Bernard-Soulier thrombopathy: a diagnostic pitfall].
Chemlal K; Grange MJ; Huisse MG
Ann Med Interne (Paris); 2002 Sep; 153(5):345-7. PubMed ID: 12442081
[TBL] [Abstract][Full Text] [Related]
20. Gastric angiodysplasia in a child with Bernard-Soulier syndrome: efficacy of octreotide in long-term management.
Kaya Z; Gürsel T; Dalgic B; Aslan D
Pediatr Hematol Oncol; 2005; 22(3):223-7. PubMed ID: 16020106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
